Evaluation of Thyroid Hormones and AntiThyroglobulin Antibodies among Sudanese Polycystic Ovarian Syndrome Patients-Reference-Cited by-同舟云学术

Evaluation of Thyroid Hormones and AntiThyroglobulin Antibodies among Sudanese Polycystic Ovarian Syndrome Patients

Published:2020-09-26 Issue:3 Volume:27 Page:191-194
ISSN:1223-0472
Container-title:Medicina Moderna - Modern Medicine
language:
Short-container-title:Rev. Med. Mod.

Author:

KAMIL Rofida Abuobaida¹,ABUBAKER Nuha Eljailli²,MOHAMED Seifeldeen Ahmed²,IBRAHIM Mariam Abbas²,ABD ALLA Ahmed Bakheet³

Affiliation:

1. Department of Clinical Chemistry, Faculty of Medical Laboratories Sciences, Alneelain University, Khartoum, Sudan

2. Department of Clinical Chemistry, College of Medical Laboratory Science, University of Science and Technology, Khartoum, Sudan

3. Department of Parasitology and Medical Entomology, College of Medical Laboratory Science, University of Science and Technology, Khartoum, Sudan

Abstract

Background: Polycystic ovarian syndrome (PCOS) and thyroid disorders are the most common endocrine disorders in women. Evidently, the involvement of polycystic ovarian syndrome (PCOS) and thyroid autoimmunity triggering thyroid disorders has not yet occurred. Objective: The aim was to assess serum free tri-iodothyronine (FT3), free thyroxin (FT4) and anti-thyroglobulin antibodies among polycystic ovary syndrome Sudanese patients. Materials and methods: Fifty Sudanese patients diagnosed with PCOS and 50 healthy age matched females were recruited in this cross-sectional controlled study. Serum FT3 and FT4 were measured by an immunoassay analyzer and serum anti-thyroglobulin antibodies were measured using ELISA. The data was then analyzed using the SPSS. Results: The results showed a signifi cant increase in serum FT3 and anti-thyroglobulin antibodies and there was no statistical difference in PCOS serum FT4 levels compared to the control group. The results revealed no correlation between levels of FT3, FT4 and anti-thyroglobulin antibodies with age; also there were no correlation between levels of FT3 and FT4 with BMI while there was a positive correlation between anti-thyroglobulin antibodies levels and BMI. Conclusion: Patients with PCOS had elevated FT3 and antithyroglobulin. Therefore, the assessment of thyroid autoantibody with thyroid hormones in patients with PCOS should be investigated.

Publisher

CMMB-Colegiul Medicilor Municipiul Bucuresti

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference19 articles.

1. 1. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6:1–13. https://www.ncbi.nlm.nih.gov › pubmed

2. 2. Witchel SF, Oberfi eld S, Rosenfi eld R, Codner E, Bonny A, Ibanez L, et al. The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr. 2015; 83:376-389. https://doi.org/10.1159/000375530.

3. 3. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. FertilSteril. 2004;81:19–25. https://www.researchgate.net publication › 278120447_The_Rotterdam .

4. 4. Exp ert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA. 2001;285:2486–2497. https://www.ncbi.nlm.nih.gov› pubmed

5. 5. Ramanand SJ, Ghongane BB, Ramanand JB, Patwardhan MH, Ghanghas RR, Jain SS. Clinical characteristics of polycystic ovary syndrome in Indian women. Indian J EndocrinolMetab. 2013;17:138–145. www.ijem.in › article › issn